GBS|CIDP Foundation International Announces the Application and Competition for the First Benson Clinical Research Fellowship for Peripheral Inflammatory Neuropathy

NARBERTH, Pa., May 13, 2014 /PRNewswire/ -- The GBS|CIDP Foundation International has announced a competition for the first Benson Clinical Research Fellowship. The Fellowship will provide funds (up to $150k per year for three years) to enable clinicians or non-clinical scientists in training, or having recently completed training, to engage in a substantial research project in the field of inflammatory neuropathy at a Center or Centers of Excellence.

Preference will be given to candidates who intend to pursue a long-term career in this field. Applicants should obtain application forms from Camille Yee at [email protected]. Completed forms should be submitted by email to Camille Yee at [email protected] by midnight EST Friday, June 20, 2014.

Short-listed candidates may be required to make a presentation at the 13th International Symposium of the GBS|CIDP Foundation International Friday, October 31, 2014 – Sunday, November 2, 2014, at Walt Disney World, Lake Buena Vista, Florida.

Guillain-Barre' Syndrome (GBS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), and Multifocal Motor Neuropathy (MMN) are extremely rare peripheral inflammatory neuropathy disorders. These disorders can be life threatening or permanently disabling, so anyone who has one of these disorders needs to get the right diagnosis and the right treatment, right away.

About GBS|CIDP Foundation International

The Foundation, founded in 1981 by Robert and Estelle Benson, is dedicated to improving the quality of life for individuals and families worldwide affected by GBS, CIDP, MMN, and their variants. Its activities include: providing a network for all patients, their caregivers and families; developing and presenting public and professional educational programs; sponsoring research; and engaging in patient advocacy.

The Foundation's vision is that every person afflicted with GBS, CIDP, MMN, or a variant should have convenient access to early and accurate diagnosis, appropriate and affordable treatments, and dependable support services.

The GBS|CIDP Foundation International has a membership of over 35,000 patients and family members affected by the challenges of GBS, CIDP, MMN, and their variants who receive support from 190 chapters located in 46 countries around the world.

Contact us to Find out More 
Friend us on Facebook 
Follow us on Twitter 

For further information, please contact:
Ken Singleton, Executive Director
GBS|CIDP Foundation International
(610) 667-0131
[email protected] 
www.gbs-cidp.org

Logo - http://photos.prnewswire.com/prnh/20131108/PH13565LOGO

SOURCE GBS/CIPD Foundation International

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED